Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.
Guide SV, Gonzalez ME, Bağcı IS, Agostini B, Chen H, Feeney G, Steimer M, Kapadia B, Sridhar K, Quesada Sanchez L, Gonzalez F, Van Ligten M, Parry TJ, Chitra S, Kammerman LA, Krishnan S, Marinkovich MP. Guide SV, et al. Among authors: parry tj. N Engl J Med. 2022 Dec 15;387(24):2211-2219. doi: 10.1056/NEJMoa2206663. N Engl J Med. 2022. PMID: 36516090 Clinical Trial.
Preclinical Evaluation of a Modified Herpes Simplex Virus Type 1 Vector Encoding Human TGM1 for the Treatment of Autosomal Recessive Congenital Ichthyosis.
Freedman JC, Parry TJ, Zhang P, Majumdar A, Krishnan S, Regula LK, O'Malley M, Coghlan S, Yogesha SD, Ramasamy S, Agarwal P. Freedman JC, et al. Among authors: parry tj. J Invest Dermatol. 2021 Apr;141(4):874-882.e6. doi: 10.1016/j.jid.2020.07.035. Epub 2020 Sep 22. J Invest Dermatol. 2021. PMID: 32976879 Free article.
Improvement in edema and cognitive recovery after moderate traumatic brain injury with the neurosteroid prodrug NTS-104.
Balleste AF, Alvarez JC, Placeres-Uray F, Mastromatteo-Alberga P, Torres MD, Dallera CA, Dietrich WD, Parry TJ, Verdoorn TA, Billing CB Jr, Buller B, Atkins CM. Balleste AF, et al. Among authors: parry tj. Neurotherapeutics. 2024 Oct;21(6):e00456. doi: 10.1016/j.neurot.2024.e00456. Epub 2024 Oct 4. Neurotherapeutics. 2024. PMID: 39366874 Free PMC article.
Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury.
Verdoorn TA, Parry TJ, Pinna G, Lifshitz J. Verdoorn TA, et al. Among authors: parry tj. Neurotherapeutics. 2023 Oct;20(6):1603-1615. doi: 10.1007/s13311-023-01428-7. Epub 2023 Aug 31. Neurotherapeutics. 2023. PMID: 37653253 Free PMC article. Review.
Pharmacological Characterization of a Novel Neuroactive Steroid Prodrug, NTS-104, and Its Neuroprotective Activity in Experimental Stroke Models.
Zhang L, Schwartz-Byrne R, Gertz S, McGuire M, Woodhouse C, Powell B, Wei M, Li C, Billing CB, Verdoorn TA, Lam L, Parry TJ, Buller B, Zhang ZG, Poulsen D, Chopp M. Zhang L, et al. Among authors: parry tj. Stroke. 2022 Nov;53(11):3455-3464. doi: 10.1161/STROKEAHA.122.038507. Epub 2022 Sep 27. Stroke. 2022. PMID: 36168130
Transient Changes in Hepatic Physiology That Alter Bilirubin and Bile Acid Transport May Explain Elevations in Liver Chemistries Observed in Clinical Trials of GGF2 (Cimaglermin Alfa).
Mosedale M, Button D, Jackson JP, Freeman KM, Brouwer KR, Caggiano AO, Eisen A, Iaci JF, Parry TJ, Stanulis R, Srinivas M, Watkins PB. Mosedale M, et al. Among authors: parry tj. Toxicol Sci. 2018 Feb 1;161(2):401-411. doi: 10.1093/toxsci/kfx222. Toxicol Sci. 2018. PMID: 29069498
48 results